Allermine Tablets Uses

Allermine tablets contain chlorpheniramine maleate, a first-generation antihistamine, and are primarily used for the symptomatic relief and treatment of various allergic conditions.[1]

  • Respiratory allergies: Including acute and chronic conditions such as seasonal and perennial allergic rhinitis (hay fever), nasal congestion, and sinus congestion.[1][6]
  • Allergic reactions: Such as urticaria (hives), contact dermatitis, food or drug allergies, insect bites, vasomotor rhinitis, and angioedema (Quincke’s edema).[1][3]
  • Other symptoms: Relief from itching due to measles, chickenpox, and allergic conjunctivitis (itchy, watery eyes), as well as sneezing and itchy throat/nose.[2][5]
  • Additional uses: Occasionally used for vertigo, as an appetite stimulant, for morning sickness, and for motion sickness (though these uses are less common and should only be on physician’s advice).[5]

Allermine tablets provide rapid symptom relief that typically lasts 4–6 hours, and the usual dosage for adults and children above 12 years is one 4mg tablet every 4–6 hours. Dosage for younger children varies based on age and physician recommendation.[3]

Common side effects include dry mouth, sleepiness, loss of appetite, nausea, fatigue, blurred vision, and, rarely, impaired coordination.[2][5] Drowsiness is among the most common side effects; patients should avoid tasks requiring full alertness, such as driving, until individual effects are known.[7]

Contraindications: Allermine is not recommended for those with hypersensitivity to its components, acute asthma attacks, prostatic hypertrophy, narrow-angle glaucoma, urinary obstructions, peptic ulcers, pregnant or breastfeeding women, neonates, or those taking monoamine oxidase inhibitors within the previous 14 days.[1]

It is essential to use Allermine tablets only under medical guidance, especially in patients with pre-existing medical conditions or those taking multiple medications, due to the potential for drug interactions and enhanced side effects.[1][6]

References

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *